Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/NAN.0000000000000267 http://scihub22266oqcxt.onion/10.1097/NAN.0000000000000267 C5862007!5862007 !29489705     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29489705 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Infus+Nurs 2018 ; 41 (2 ): 103-112 Nephropedia Template TP {{tp|p=29489705 |t=2018. Antimicrobial Efficacy of a New Chlorhexidine-based Device Against Staphylococcus aureus Colonization of Venous Catheters |pdf=|usr=}}{{29489705 }} gab.com Text Antimicrobial Efficacy of a New Chlorhexidine-based Device Against Staphylococcus aureus Colonization of Venous Catheters JO: J Infus Nurs http://www.kidney.de/pget.php?&tw=1&pmid=29489705 #FOAvip Vascular catheters are a major cause of nosocomial bloodstream infections. ChloraLock (ATTWILL Medical Solutions, Inc, West Jordan, UT, and ICU Medical, Inc, San Clemente, CA) is a novel antimicrobial device containing chlorhexidine digluconate (CHG) that is fitted onto a syringe and infuses CHG into the catheter lumen during locking. The objective of this study was to evaluate the antimicrobial efficacy of ChloraLock with in vitro tests and its ability to reduce Staphylococcus aureus contamination of catheters in the external jugular veins of Yorkshire swine. ChloraLock significantly reduced the bacterial load in the in vitro tests by up to 6 log10 colony-forming units (CFU) and by 3 to 4 log10 CFU/lumen in vivo in a swine model with 0.9% NaCl catheter locks. Twit Text FOAVip Antimicrobial Efficacy of a New Chlorhexidine-based Device Against Staphylococcus aureus Colonization of Venous Catheters ????J Infus Nurs http://www.kidney.de/pget.php?&tw=1&pmid=29489705 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29489705 #FOAvip English Wikipedia <ref>{{Cite pmid|29489705 }}</ref> Antimicrobial Efficacy of a New Chlorhexidine-based Device Against Staphylococcus aureus Colonization of Venous Catheters #MMPMID29489705 Kowalewska PM ; Petrik SM ; Di Fiore AE ; Fox-Robichaud AE J Infus Nurs 2018[Mar]; 41 (2 ): 103-112 PMID29489705 show ga Vascular catheters are a major cause of nosocomial bloodstream infections. ChloraLock (ATTWILL Medical Solutions, Inc, West Jordan, UT, and ICU Medical, Inc, San Clemente, CA) is a novel antimicrobial device containing chlorhexidine digluconate (CHG) that is fitted onto a syringe and infuses CHG into the catheter lumen during locking. The objective of this study was to evaluate the antimicrobial efficacy of ChloraLock with in vitro tests and its ability to reduce Staphylococcus aureus contamination of catheters in the external jugular veins of Yorkshire swine. ChloraLock significantly reduced the bacterial load in the in vitro tests by up to 6 log10 colony-forming units (CFU) and by 3 to 4 log10 CFU/lumen in vivo in a swine model with 0.9% NaCl catheter locks. |*Catheterization, Central Venous/adverse effects/instrumentation [MESH] |*Equipment Design [MESH] |Animals [MESH] |Anti-Infective Agents/*administration & dosage [MESH] |Catheter-Related Infections/microbiology/*therapy [MESH] |Chlorhexidine/administration & dosage/*analogs & derivatives [MESH] |Disease Models, Animal [MESH] |Jugular Veins/microbiology [MESH] |Staphylococcus aureus/*growth & development/virology [MESH]Antimicrobial Efficacy of a New Chlorhexidine-based Device Against Sta(epmc).pdf DeepDyve Pubget Overpricing